C12Y 203/01026
Sterol o-acyltransferase
Official title: Sterol O-acyltransferase (2.3.1.26)
C12Y203/01026 (Sterol o-acyltransferase) appears on 14 US grants and 23 published applications in this corpus.
Search patents in C12Y- Granted patents
- 14
- Published applications
- 23
- Assignees
- 9
- Inventors
- 44
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 3 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 1 | 4 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 0 | 0 |
| 2014 | 2 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 3 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 3 |
| 2022 | 1 | 3 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 2 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modified sterol acyltransferases19 May 2026US 12,630,852 B2Dsm IP Assets B.V.
- Use of Acyl coenzyme A: cholesterol acyltransferase-1 in diagnosis and treatment of liver cancer3 Feb 2026US 12,540,943 B2Academy of Military Medical Sciences
- Modified sterol acyltransferases18 Feb 2025US 12,227,772 B2Dsm IP Assets B.V.
- Biosynthesis of cannabinoids and cannabinoid precursors15 Mar 2022US 11,274,320 B2Ginkgo Bioworks, Inc.
- Production of fatty alcohols in Rhodosporidium15 Jun 2021US 11,034,981 B2Temasek Life Sciences Laboratory Limited
- Biosynthesis of cannabinoids and cannabinoid precursors29 Sep 2022US 2022/0307060 A1Ginkgo Bioworks, Inc.
- Biosynthesis of cannabinoids and cannabinoid precursors23 Jun 2022US 2022/0195472 A1Ginkgo Bioworks, Inc.
- Use of acyl coenzyme a: cholesterol acyltransferase-1 in diagnosis and treatment of liver cancer3 Feb 2022US 2022/0034891 A1Beijing Proteome Research Center
- Modified sterol acyltransferases22 Apr 2021US 2021/0115412 A1Dsm IP Assets B.V.
- Modified sterol acyltransferases1 Apr 2021US 2021/0095325 A1Dsm IP Assets B.V.
Most cited
By later US patents
- Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression110US 7,202,357 B2Isis Pharmaceuticals, Inc. · 2007
- Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression109US 7,335,764 B2Isis Pharmaceuticals, Inc. · 2008
- Genetically modified organism for the production of lipids4US 8,841,114 B2Organobalance GmbH · 2014